Crossmark

Who is more likely to adopt and comply with the electronic patient-reported outcome measure (ePROM) mobile application? A real-world study with cancer patients undergoing active treatment

Crossref DOI link: https://doi.org/10.1007/s00520-021-06473-6

Published Online: 2021-08-07

Published Print: 2022-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lee, Mangyeong

Kang, Danbee

Kim, Sooyeon

Lim, Jihyun

Yoon, Junghee

Kim, Youngha

Shim, Sungkeun

Kang, Eunji

Ahn, Jin Seok

Cho, Juhee

Shin, Soo-Yong

Oh, Dongryul
Funding

Funding for this research was provided by:

National Research Foundation of Korea (1711068113, 1345317573)

samsung medical center (SMX1210381)
License Information

Text and Data Mining valid from 2021-08-07

Version of Record valid from 2021-08-07
More Information

Article History

Received: 17 May 2021

Accepted: 26 July 2021

First Online: 7 August 2021

Declarations

:

: The study was approved by the Institutional Review Board of the Samsung Medical Center (SMC 2017–06-033).

: Informed consent was obtained from all individual participants included in the study.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below